A study published online in The Lancet Oncology showed a score integrating clinical and biological markers which could help foresee the chance of mortality in patients with malignant pleural effusion and their probability of benefiting from pleurodesis.
Pre-exposure prophylaxis (PrEP) by U.S. residents against HIV infection has resulted in positive outcomes. Incidence of new HIV infections among those 13 years old and above fell during 2012 - 2016, and this plunge presented a statistically noteworthy association with an increase in drug prophylaxis among U.S. residents in the same duration.
Findings from a study conducted by Prof. Marco Falasca from Queen Mary University of London (QMUL) in the United Kingdom and team on a mouse model of pancreatic cancer, which they injected with cannabidiol (CBD), naturally occurring cannabis along with a classic chemotherapy drug, Gemcitabine, revealed that the rodents lived almost three times more than mice from a control group, which had been treated with Gemcitabine only.
Researchers from Project Insecurity unraveled the disturbing fact the millions of patient records were lying rather bare to attack from potential hackers. 18 grave vulnerabilities were discovered before OpenEMR tackled the issues.
A new paper published in Medicine suggests that Heat shock proteins CPN10, CPN60, and CPN70 could act as biomarkers for bipolar disorder (BD). Moreover, CPN60 serum levels could act as a biomarker to specify which BD patients have abnormal activity of the hypothalamic-pituitary-adrenal (HPA) axis.
Researchers headed by Charlotte M. Wright, MBBS, MSc, MD, professor, Community Child Health, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, Scotland, UK, wrote in Pediatric Obesity,“‘Obesity’ in infancy is not, in fact, an important risk factor for obesity in childhood,”
A research team in the US confirmed the effectiveness of three doses of quadrivalent human papillomavirus (HPV) vaccine among women aged 20 years and younger, however, more research is needed for women aged between 21-26 years.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.